Skip to main content

Table 3 Correlates of HCV antibody-positive serostatus among young adult PWID (n = 347)

From: Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose

 HCV−HCV+Unadjusted OR (95% CI)OR p valueAOR (95% CI)AOR p value
N (%)264 (71)101 (29)
Injected POs (lifetime)
 No117 (48)22 (22)RefRefRefRef
 Yes129 (52)79 (78)3.26 (1.91–5.56)< 0.012.28 (1.26–4.13)< 0.01
Gender
 Male89 (64)138 (68)RefRef  
 Female50 (36)66 (32)1.01 (0.62–1.65)0.96
Race/ethnicity
 Latino/a46 (19)18 (18)RefRef  
 White181 (74)75 (74)1.06 (0.58–1.94)0.85
 Non-Latino and non-White17 (7)8 (8)1.20 (0.44–3.27)0.13
Household income growing up (annual)
 $0–50 k89 (38)36 (43)RefRef  
 $51–100 k79 (34)33 (39)1.03 (0.59–1.81)0.91  
 > $100 k65 (28)15 (18)0.57 (0.28–1.13)0.11  
Homeless (lifetime)
 No92 (37)11 (11)RefRefRefRef
 Yes154 (63)89 (89)4.83 (2.46–9.52)< 0.013.30 (1.62–6.71)< 0.01
Number people shared syringes (past 12 months)
 0155 (67)45 (46)RefRefRefRef
 159 (25)28 (28)1.64 (0.94–2.86)0.081.16 (0.61–2.18)0.65
 2 or more18 (8)26 (26)4.98 (2.50–9.88)< 0.012.16 (0.96–4.87)0.06
Number people shared cookers (past 12 months)
 0108 (47)24 (24)RefRefRefRef
 153 (23)17 (17)1.44 (0.72–2.92)0.311.38 (0.63–3.02)0.41
 2 or more70 (30)58 (59)3.73 (2.12–6.55)< 0.012.52 (1.31–4.83)< 0.01
  1. Sample total is 347 instead of 353 because 6 participants did not respond to the series of questions regarding PO injection